Home World BRIEF-KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study

BRIEF-KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study

BRIEF-KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study

Written By:
Published: October 15, 2026 11:19:12 IST

Add NewsX As A Trusted Source

Oct 15 (Reuters) – Kdventures AB: * PORTFOLIO COMPANY MODUS THERAPEUTICS TEMPORARILY PAUSES ENROLLMENT IN PHASE 2A STUDY OF SEVUPARIN IN CHRONIC KIDNEY DISEASE WITH ANEMIA * PAUSE IS NOT RESULT OF A

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

BRIEF-Niewiadow PGM Appoints Andrzej Kensbok As CEO

BRIEF-Sipef Q3 Crude Palm Oil Output At 136,927 Tonnes

French and Benelux stocks-Factors to watch

UPDATE 1-IMF warns of slowing Asian growth, spillover from rising yields

UPDATE 10-MLS Summaries

LATEST NEWS

Some fatty foods could be a help against cancer, scientists find

Brewers' late home runs put Dodgers on brink of NLCS exit

Make this German-style onion tart for a light yet cosy evening meal

Cost of AI default insurance spikes as data centre confidence wobbles

Cost of AI default insurance spikes as data centre confidence wobbles

River Plate battle back to draw 1-1 with tough Sarmiento side in APL action

BRIEF-KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study

TSMC reports sixth straight quarter of record profit thanks to AI boom

TSMC Q3 profit jumps 69% to record, beating expectations

River Plate battle back to draw 1-1 with tough Sarmiento side in APL action

Follow Us

NewsX is India’s fastest growing English News Channel and enjoys highest viewership and highest time spent amongst educated urban Indians.

TOP CATEGORIES

QUICK LINKS

Follow Us

NewsX is India’s fastest growing English News Channel and enjoys highest viewership and highest time spent amongst educated urban Indians.

TOP CATEGORIES

Group Websites

QUICK LINKS